Milestone Pharmaceuticals Inc (MIST)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $45.44M
Last updated: Nov 17, 2026 at 4:43 PM ET
Milestone Pharmaceuticals Inc (MIST) Stock Chart
Milestone Pharmaceuticals (MIST) has a latest price of $0.41 on Nov 17, 2026, 86.5% below its 52-week high of $3.06. Its price fell 79.3% over the past 12 months. The month-end price fell 87.0% over the 5 years through Oct 2026, a compound annual decline of 33.5%.
Price Chart
From May 2019 to Oct 2026, its highest month-end close was $27.15 in Jun 2019 and its lowest $0.73 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart MIST with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MIST.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 61.7%, and over 6 months it fell 71.1%. The month-end price fell 71.5% over the 3 years through Oct 2026, a compound annual decline of 34.2%.
| Period | Change |
|---|---|
| 1 month | -41.0% |
| 3 months | -61.7% |
| 6 months | -71.1% |
| 12 months | -79.3% |
| 12 months, with dividends | -79.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -71.5% | -34.2% |
| 5 years | -87.0% | -33.5% |
Price by Year
Its best calendar year was 2024, when the price rose 41.3%, and its weakest was 2020, when it fell 58.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.73 | -63.9% |
| 2025 | $2.02 | -14.4% |
| 2024 | $2.36 | +41.3% |
| 2023 | $1.67 | -57.8% |
| 2022 | $3.96 | -39.5% |
| 2021 | $6.55 | -2.2% |
| 2020 | $6.70 | -58.2% |
Trading Range
The price is 46.4% below its 50-day average of $0.77 and 68.1% below its 200-day average of $1.29.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.41 | |
| 52-week high | $3.06 | -86.5% |
| 52-week low | $0.36 | +14.1% |
| 50-day average | $0.77 | -46.4% |
| 200-day average | $1.29 | -68.1% |
Price Risk
Over 3 years, its largest fall from a peak was 89.2%.
| Measure | Value |
|---|---|
| 1-year beta | 2.80 |
| Largest fall, 1 year | -87.6% |
| Largest fall, 3 years | -89.2% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About MIST
What is MIST's 1-year price change?
Milestone Pharmaceuticals's price fell 79.3% over the past 12 months. With dividends included, the 12-month total return was -79.3%.
What is MIST's 5-year price change?
Milestone Pharmaceuticals's month-end price fell 87.0% over the 5 years through Oct 2026, a compound annual decline of 33.5%. These figures leave out dividends.
What is MIST's 52-week high and low?
Milestone Pharmaceuticals's 52-week high is $3.06 and its 52-week low is $0.36. Its latest price of $0.41 on Nov 17, 2026 is 86.5% below the high.
What is MIST's beta?
Milestone Pharmaceuticals's 1-year beta against the S&P 500 is 2.80, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 87.6%.
Is the MIST chart free?
Yes. Advanced Charting for MIST is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
MIST pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors